JPM Thematics - Genetic Therapies I2 Fonds
107,33
EUR
+0,55
EUR
+0,52
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Krystal Biotech Inc | US5011471027 | 3,32% |
| Novartis AG Registered Shares | CH0012005267 | 3,30% |
| Astellas Pharma Inc | JP3942400007 | 3,25% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,22% |
| Arrowhead Pharmaceuticals Inc | US04280A1007 | 3,19% |
| PTC Therapeutics Inc | US69366J2006 | 3,12% |
| Gilead Sciences Inc | US3755581036 | 3,07% |
| Amgen Inc | US0311621009 | 3,01% |
| Sumitomo Pharma Co Ltd | JP3495000006 | 2,69% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 2,68% |
| Sonstige | 69,14% |